Treatment Trial for Post-Thrombotic Syndrome

Completed · Not applicable

Conditions studied: Post Thrombotic Syndrome

In brief

The purpose of this study is to determine if complex lymphedema therapy is effective in decreasing disease severity and improving quality of life in patients with post thrombotic syndrome.

Key facts

Study ID

NCT00633971

Run by

University of Vermont

People needed

31

Starts

2008-03-01

Expected to finish

2011-09-01

Last updated by the study team

2020-09-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age >18 years.
• Diagnosis of post thrombotic syndrome.
• Median life expectancy of greater than 2 years.
• Previous history of lower extremity deep venous thrombosis.

You may not qualify if…

• Acute venous thrombosis of the lower extremity within the last 180 days.
• Unable to participate in lymphedema therapy due to monetary, physical or transportation limitations.
• Uncontrolled illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.
• Pregnant women and women in their first post-partum month.

Where it is running

• Fletcher Allen Health Care; Department of Hematology/Oncology — Burlington, Vermont, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.